Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings
about
Postmenopausal estrogen and progestin effects on the serum proteome.Detection of elevated plasma levels of epidermal growth factor receptor before breast cancer diagnosis among hormone therapy users.Concordant release of glycolysis proteins into the plasma preceding a diagnosis of ER+ breast cancer.The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women.Intact-protein analysis system for discovery of serum-based disease biomarkers.Integrative proteomic analysis of serum and peritoneal fluids helps identify proteins that are up-regulated in serum of women with ovarian cancerNovel proteins associated with risk for coronary heart disease or stroke among postmenopausal women identified by in-depth plasma proteome profilingDiscovery and validation of breast cancer early detection biomarkers in preclinical samplesNovel effects of hormonal contraceptive use on the plasma proteome.Postmenopausal hormone therapy and the risks of coronary heart disease, breast cancer, and stroke.Confounding effects of hormone replacement therapy in protein biomarker studies.Progress in mining the human proteome for disease applicationsAn Autoimmune Response Signature Associated with the Development of Triple-Negative Breast Cancer Reflects Disease Pathogenesis.Proteomic profiling of the autoimmune response to breast cancer antigens uncovers a suppressive effect of hormone therapy.Exploring the interaction between SNP genotype and postmenopausal hormone therapy effects on stroke riskPositive association between 25-hydroxyvitamin D and C-reactive protein is confounded by hormonal contraceptive useUsing a global proteomic approach to identify proteins affected by estrogen therapyA novel soluble form of Tim-3 associated with severe graft-versus-host disease.Proteomic risk markers for coronary heart disease and stroke: validation and mediation of randomized trial hormone therapy effects on these diseases.Proteomic analysis of venous thromboembolism.Proteomic analysis of venous thromboembolism: an update.Assessing biological and technological variability in protein levels measured in pre-diagnostic plasma samples of women with breast cancerMenopause and mitochondria: windows into estrogen effects on Alzheimer's disease risk and therapy.Estrogen increases the transcription of human α2-Heremans-Schmid-glycoprotein by an interplay of estrogen receptor α and activator protein-1.Effects of oral conjugated equine estrogens with or without medroxyprogesterone acetate on incident hypertension in the Women's Health Initiative hormone therapy trials.Plasma matrix metalloproteinase 2 levels and breast cancer risk.
P2860
Q33600109-F030E0C4-9C5A-4E28-AEED-DF6F0C27603AQ33722935-C144DC48-4F3B-4B5A-ACF1-13640DF09110Q33790538-313B1742-56C2-4726-A6F6-C3CE27245153Q33838504-22D0C987-D33C-4A1A-A851-CD9ED5A17463Q33863832-0BB9ED0F-3905-44C5-A98B-3544007856EFQ33915144-13ED82BA-289A-44BF-A6BE-FBBA1305DE71Q34073510-D0D10258-84BB-497F-881D-05B56A1E61B2Q34200678-0EC9B31F-E483-4D53-8732-755EBC7814EBQ34416417-29F74E54-9698-477A-88CE-B4E3FE14C8BBQ34420014-E84B5828-626F-4B15-8C05-DE588B0D86ADQ35051095-E3560EAE-9BC3-49A4-B17B-5336D03B0E63Q35056154-3C67E8A7-95B8-44BE-839A-078032CA9C47Q36365669-ECFB996B-AFC5-4F54-80A4-2494566A41B8Q36377157-146A5465-7669-4E98-A3C5-9C3A207F0D1CQ36632865-FFDE8F1C-4E75-43BC-A741-3EBB1FA6E620Q36842132-D3C6E85A-239E-41E4-AFF1-E88C4EC368F9Q37245536-678E602B-D494-44E8-9322-CE38071FF9CBQ37665262-A61428BC-C7C8-4A37-BB2B-E82AF9F081AEQ37676826-3BA791E8-8228-4894-A95D-F02E5A8CBDA9Q37727202-1ADFA9FD-54BC-4309-86AB-0552726FBFDDQ38097846-E7C61A65-C7FA-4EF6-98FA-63500BD6AFC8Q42682509-C06936AA-8638-4D9D-B520-FEE701ECF0F9Q43028519-54479C05-2B81-4556-97EB-50D6A447BDDDQ44515817-EC9D96DC-4951-4953-8D74-EC1ED2A7660CQ49578334-C52678CC-223E-4D18-9673-47D17D8CBE34Q53568806-FC5C95E4-C6AF-42B7-9225-550D3156F1E1
P2860
Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Application of serum proteomic ...... relevant to clinical findings
@en
Application of serum proteomic ...... relevant to clinical findings.
@nl
type
label
Application of serum proteomic ...... relevant to clinical findings
@en
Application of serum proteomic ...... relevant to clinical findings.
@nl
prefLabel
Application of serum proteomic ...... relevant to clinical findings
@en
Application of serum proteomic ...... relevant to clinical findings.
@nl
P2093
P2860
P356
P1433
P1476
Application of serum proteomic ...... relevant to clinical findings
@en
P2093
Aaron Aragaki
Hiroyuki Katayama
Jacob Kennedy
Jacques Rossouw
Joann Manson
Judith Hsia
Melissa Silva
Qing Zhang
Rebecca Jackson
P2860
P2888
P356
10.1186/GM47
P577
2009-04-29T00:00:00Z
P5875
P6179
1034156682